Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases.

Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases. Abstract Text:

Athol U Wells,Andrew G Nicholson,David M Hansell,Athol U Wells,Andrew G Nicholson,David M Hansell,

Smoking-induced diffuse interstitial lung processes include respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease (RBILD), desquamative interstitial pneumonia (DIP) and Langerhans' cell histiocytosis. The histological, radiological and clinical features of respiratory bronchiolitis, RBILD and DIP are reviewed, with particular reference to management issues; Langerhans' cell histiocytosis is covered elsewhere in this series of articles. Possible relationships between smoking and other diffuse lung diseases are explored briefly.

Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases. Publishing Authors By Initials

AU Wells,AG Nicholson,DM Hansell,AU Wells,AG Nicholson,DM Hansell,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Thorax

VOLUME: 62

Page Numbers: 904-10

Journal Abbreviation: Thorax

ISSN: 0040-6376

DAY: 2

MONTH: Oct

YEAR: 2007

Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 417353

Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases.

AFFILIATION: Interstitial Lung Disease Unit, Royal Brompton Hospital, Emmanuel Kaye Building, Manresa Road, London SW3 6LR, UK. a.wells@rbh.nthames.nhs.uk

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Thorax

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Challenges in pulmonary fibrosis 4: smoking-induced diffuse interstitial lung diseases Related Publications

• Airborne environmental exposure to asbestos.
• CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types.
• Challenges in pulmonary fibrosis . 4: smoking-induced diffuse interstitial lung diseases.
• Chapter and verse on why lung disease is under-recognised and underestimated.
• Diagnostic accuracy of thin-section CT and chest radiography of pediatric interstitial lung disease.
• Evidence of expiratory CT scans of small-airway obstruction in sarcoidosis.
• Functional impairment in emphysema: contribution of airway abnormalities and distribution of parenchymal disease.
• Glaucoma as post operative complication of hysterectomy, oophorectomy, enterectomy and enteroenterostomy.
• Hormonal regulation of renomedullary hyaluronan.
• Intercomparison and coupling of magnesium-induced co-precipitation and long-path liquid-waveguide capillary cell techniques for trace analysis of phosphate in seawater.
• J. L. Hansell.
• Nest building by birds.
• Next steps for mental health service in Illinois--an assessment of several policy instruments.
• Pericardial thickening or effusion in patients with pulmonary artery hypertension: a CT study.
• Renal hyaluronan content during experimental uncontrolled diabetes in rats.
• Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.
• Small chronic pneumothoraces and pulmonary parenchymal abnormalities after bone marrow transplantation.
• Some observations on dermatological photography.